Genfit’s elafibranor hits goal in phase 2 PBC trial
2 Oct 2019A phase 2 trial of Genfit’s elafibranor in primary biliary cholangitis (PBC) has hit its ...
Latest News
A bioethicist says scientists owe clinical trial volunteers support
7 Nov 2019Some people see clinical trials as a chance for a miracle cure. In reality, these experimental drug tests and medical interventions often fail. With researchers...
Infectious Diseases Clinical Research Consortium awards announced
12 Jan 2019The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, today announced the establishment of...
Our mission and vision
Founded in 2007, Apex Oncology is dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs. Operating with a global footprint in over 10 countries, Apex Oncology enables our clients to access solutions even for their toughest clinical development and trial management challenges from early phase to complex late stage programmes. Apex Oncology has provided and managed clinical development, trial management and pharmacovigilance services for over 20 clients: these range from top 10 pharmaceutical and generics organizations to small and mid-sized drug development companies.
Research summaries
Our Expertise
Our services support the clinical development and product life cycle for: pharmaceutical, biotechnology, medical devices, dietary supplements, food for particular medical purposes and phytochemicals in the following therapeutical areas: Oncology, Hematology, HIV-AIDS, CNS, Immunology, Hepathology-Gastroenterology, Ob-Gyn, UTI, ID, Respiratory, Pediatric, Dermatology, Allergology, Rheumatology, Ophthalmology, Intensive Care, Anesthesia
See details